Two new studies found that gene profiling based on blood samples was able to identify early predictors of treatment response in rheumatoid arthritis (RA) patients. The ability to quickly identify RA patients that are not responding to treatment supports timely switching to alternative treatment, reduces the chance of long-term joint damage and saves costs on ineffective drugs

Click here for more.